GT201200335A - Procedimiento para la preparacion de diàcido 3,6.9- triaza-3,6,9-tris(carboximetil) -4-(4-etoxibencil)-undecanoico cristitalino y el uso para la preparacion de promovisto - Google Patents

Procedimiento para la preparacion de diàcido 3,6.9- triaza-3,6,9-tris(carboximetil) -4-(4-etoxibencil)-undecanoico cristitalino y el uso para la preparacion de promovisto

Info

Publication number
GT201200335A
GT201200335A GT201200335A GT201200335A GT201200335A GT 201200335 A GT201200335 A GT 201200335A GT 201200335 A GT201200335 A GT 201200335A GT 201200335 A GT201200335 A GT 201200335A GT 201200335 A GT201200335 A GT 201200335A
Authority
GT
Guatemala
Prior art keywords
preparation
etoxibencil
triaza
tris
carboximetil
Prior art date
Application number
GT201200335A
Other languages
English (en)
Inventor
Platzek Johannes
Trentmann Wilhelm
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45098458&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT201200335(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE201010023890 external-priority patent/DE102010023890A1/de
Priority claimed from BRPI1002466 external-priority patent/BRPI1002466A2/pt
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of GT201200335A publication Critical patent/GT201200335A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/38—Separation; Purification; Stabilisation; Use of additives
    • C07C227/40—Separation; Purification
    • C07C227/42—Crystallisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACIÓN DE DIÁCIDO 3,6,9-TRIAZA-3,6,9-TRIS(CARBOXIMETIL)-4-(4-ETOXIBENCIL)-UNDECANOICO CRISTALINO POR SAPONIFICACIÓN DE ÉSTER DI-TER-BUTÍLICO DEL DIÁCIDO 3,6,9-TRIAZA-3,6,9-TRIS(TER.-BITPXOCARBOMETIL)-4-(4-ETOXIBENCIL)-UNDECANOICO EN UNA SOLUCIÓN ACUOSA DE HIDRÓXIDO DE METAL ALCALINO Y EL USO DE DIÁCIDO 3,6,9-TRIAZA-3,6,9-TRIS(CARBOXIMETIL)-4-(4-ETOXIBENCIL)-UNDECANOICO PARA LA PREPARACIÓN DEL COMPLEJO DE GADOLINIO DE DIÁCIDO 3,6,9-TRIAZA-3,6,9-TRIS(CARBOXIMETIL)-4-(4-ETOXIBENCIL)-UNDECANOICO [(GD-EOB-DTPA)=PRIMOVIST®]
GT201200335A 2010-06-11 2012-12-11 Procedimiento para la preparacion de diàcido 3,6.9- triaza-3,6,9-tris(carboximetil) -4-(4-etoxibencil)-undecanoico cristitalino y el uso para la preparacion de promovisto GT201200335A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE201010023890 DE102010023890A1 (de) 2010-06-11 2010-06-11 Verfahren zur Herstellung kristalliner 3,6,9-Triaza-3,6,9-tris(carboxymethyl)-4-(ethoxybenzyl)-undecandinsäure und die Verwendung zur Herstellung von Primovist
BRPI1002466 BRPI1002466A2 (pt) 2010-07-19 2010-07-19 processo para preparação de diácido 3,6,9-triaza-3,6,9-tris(carboximetil)-4-(4-etoxibenzil)-u ndecánico cristalino e seu uso para preparação de primovist«

Publications (1)

Publication Number Publication Date
GT201200335A true GT201200335A (es) 2014-03-25

Family

ID=45098458

Family Applications (1)

Application Number Title Priority Date Filing Date
GT201200335A GT201200335A (es) 2010-06-11 2012-12-11 Procedimiento para la preparacion de diàcido 3,6.9- triaza-3,6,9-tris(carboximetil) -4-(4-etoxibencil)-undecanoico cristitalino y el uso para la preparacion de promovisto

Country Status (23)

Country Link
US (1) US20130158241A1 (es)
EP (1) EP2580184A2 (es)
JP (1) JP2013531643A (es)
KR (1) KR20130111513A (es)
CN (1) CN103068790A (es)
AU (1) AU2011263890A1 (es)
CA (1) CA2801968A1 (es)
CL (1) CL2012003497A1 (es)
CO (1) CO6650345A2 (es)
CR (1) CR20120627A (es)
CU (1) CU20120168A7 (es)
EC (1) ECSP12012335A (es)
GT (1) GT201200335A (es)
IL (1) IL223553A0 (es)
MA (1) MA34304B1 (es)
MX (1) MX2012014490A (es)
PE (1) PE20130458A1 (es)
RU (1) RU2012157539A (es)
SG (1) SG186259A1 (es)
TN (1) TN2012000585A1 (es)
TW (1) TW201206876A (es)
WO (1) WO2011154333A2 (es)
ZA (1) ZA201300256B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103420862B (zh) * 2012-05-16 2015-04-22 齐鲁制药有限公司 一种钆塞酸二钠中间体化合物的金属盐、其晶型及制备方法
CN104672099A (zh) * 2013-11-27 2015-06-03 山东富创医药科技有限公司 一种新的钆塞酸二钠中间体的制备方法
CN104130146B (zh) * 2014-07-31 2016-03-02 苏州昊帆生物科技有限公司 (4s)-3，6，9-三氮杂-3，6，9-三(羧甲基)-4-(4-乙氧基苄基)十一烷二酸的制备方法
US11149041B2 (en) 2016-05-30 2021-10-19 Biophore India Pharmaceuticals Pvt. Ltd. Process for the preparation of gadolinium complex of (4S)-4-(4-ethoxybenzyl)-3,6,9-tris(carboxylatomethyl)-3,6,9-triazaundecanedioic acid disodium (Gadoxetate disodium)
CN109851516B (zh) * 2019-01-28 2020-10-02 湖北天舒药业有限公司 用于钆系造影剂中叔丁酯的水解方法
CN115876898B (zh) * 2021-09-27 2024-10-01 长沙创新药物工业技术研究院有限公司 一种聚乙二醇修饰剂的制备及纯度测定方法
CN115043747B (zh) * 2022-08-15 2022-11-25 康瑞鑫(天津)药物研究院有限公司 卡洛酸三钠的析晶方法及制备的卡洛酸三钠晶体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3640708C2 (de) 1986-11-28 1995-05-18 Schering Ag Verbesserte metallhaltige Pharmazeutika
DE3922005A1 (de) 1989-06-30 1991-01-10 Schering Ag Derivatisierte dtpa-komplexe, diese verbindungen enthaltende pharmazeutische mittel, ihre verwendung und verfahren zu deren herstellung
HUT77553A (hu) * 1994-11-30 1998-05-28 Schering Aktiengesellschaft Eljárás fémeket tartalmazó kelát komplexek alkalmazására a máj és az epe röntgendiagnosztikájában
DE19712012A1 (de) * 1997-03-13 1998-09-24 Schering Ag Verfahren zur Herstellung kristalliner 3,6,9-Triaza-3,6-9-tris(carboxymethyl)-4-(4- ethoxybenzyl)-undecandisäure

Also Published As

Publication number Publication date
KR20130111513A (ko) 2013-10-10
WO2011154333A3 (de) 2012-02-16
IL223553A0 (en) 2013-03-05
EP2580184A2 (de) 2013-04-17
CO6650345A2 (es) 2013-04-15
AU2011263890A1 (en) 2013-01-24
ZA201300256B (en) 2014-06-25
ECSP12012335A (es) 2012-12-28
MX2012014490A (es) 2013-02-07
MA34304B1 (fr) 2013-06-01
RU2012157539A (ru) 2014-07-20
US20130158241A1 (en) 2013-06-20
CU20120168A7 (es) 2013-04-19
CL2012003497A1 (es) 2013-03-22
TN2012000585A1 (en) 2014-04-01
TW201206876A (en) 2012-02-16
CR20120627A (es) 2013-03-13
CA2801968A1 (en) 2011-12-15
SG186259A1 (en) 2013-01-30
JP2013531643A (ja) 2013-08-08
CN103068790A (zh) 2013-04-24
PE20130458A1 (es) 2013-04-11
WO2011154333A2 (de) 2011-12-15

Similar Documents

Publication Publication Date Title
AR117799A2 (es) Sal(es) de dimetil-amida del ácido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-[2,3-d]-pirimidin-6-carboxílico y procesos para su elaboración
GT201200335A (es) Procedimiento para la preparacion de diàcido 3,6.9- triaza-3,6,9-tris(carboximetil) -4-(4-etoxibencil)-undecanoico cristitalino y el uso para la preparacion de promovisto
NZ704662A (en) Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid
GT201400136A (es) Compuestos y métodos de benzaldehído substituído para su uso en incrementar la oxigenación de los tejidos
EA201391392A1 (ru) Синтетические наноносители с осмотически опосредованным высвобождением
GT201400033A (es) Pirimidinas anilladas sustituidas y uso de las mismas
PE20141406A1 (es) 4-(8-metoxi-1-((1-metoxipropan-2-il)-2-(tetrahidro-2h-piran-4-il)-1h-imidazo[4,5-c]quinolin-7-il)-3,5-dimetilisoxazol y su uso como inhibidor bromodominio
ECSP10010295A (es) Formulacion de anticuerpo
CO6771428A2 (es) Composición efervescente en forma sólida para uso en aplicaciones vaginales para el tratamiento de infecciones vaginales
CR20130001A (es) Derivados de indolizina, su procedimiento de preparación y su aplicación en terapéutica
DOP2013000244A (es) Triazolopiridinas
MY159492A (en) Solid pharmaceutical formulation with delayed release
UY32052A (es) 5-aminopirazoles sustituidos y uso de los mismos
CL2012003458A1 (es) Vector que comprende un polipeptido antigénico de campylobacter; composicion farmacéutica que comprende dicho vector; uso del vector para mejorar respuesta inmune del sujeto al polipéptido antigénico.
CO7160080A2 (es) Composiciones lipídicas de racecadotrillo
AR089269A1 (es) Composiciones para el cuidado oral
CO6741197A2 (es) Proteína de fusión robo1-fc para uso en el tratamiento del hepatocarcinoma
CR11869A (es) 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos
CO6400226A2 (es) Micrólido anti-inflamatorio
CL2013000335A1 (es) Forma altamente cristalina de valsartan; proceso para prepararla; composicion farmaceutica que la comprende y uso en el tratamiento de la hipertension.
EP3138850B8 (en) Compositions containing deoxycholic acid and 10% deionized water in ethanol, directed to the purification of deoxycholic acid
DOP2012000228A (es) Procedimiento para la preparación de 2-(ciclohexilmetil)-n-{2-[(2s)-1-metilpirrolidin-2-il]etil}-1,2,3,4-tetrahidroisoquinolin-7-sulfonamida
CL2008001280A1 (es) Composicion farmaceutica que comprende una sal de aminoacido n-halogenado; procedimiento de preparacion; y su uso como antimicrobiano.
AR089079A1 (es) Formulacion de anticuerpo anti-cd44
PE20151432A1 (es) Formulaciones de lorazepam de liberacion sostenida